PL3291820T3 - Preparat hydrożelowy o łagodnej przyczepności - Google Patents

Preparat hydrożelowy o łagodnej przyczepności

Info

Publication number
PL3291820T3
PL3291820T3 PL16724201.5T PL16724201T PL3291820T3 PL 3291820 T3 PL3291820 T3 PL 3291820T3 PL 16724201 T PL16724201 T PL 16724201T PL 3291820 T3 PL3291820 T3 PL 3291820T3
Authority
PL
Poland
Prior art keywords
hydrogel formulation
mild adhesion
mild
adhesion
hydrogel
Prior art date
Application number
PL16724201.5T
Other languages
English (en)
Inventor
Christopher A. Zook
Michael T. Sweeney
Rebecca R. QUESNELL
Fiona Patricia CLEMENTS
Claude-Raymond RENÉ
Bruktawit Asfaw
Sarah Barbara KOKOTOFF
Dominic Dominicovich UGBEDAH
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL3291820T3 publication Critical patent/PL3291820T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16724201.5T 2015-05-06 2016-05-05 Preparat hydrożelowy o łagodnej przyczepności PL3291820T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562157627P 2015-05-06 2015-05-06
PCT/US2016/030961 WO2016179379A1 (en) 2015-05-06 2016-05-05 Hydrogel formulation with mild adhesion

Publications (1)

Publication Number Publication Date
PL3291820T3 true PL3291820T3 (pl) 2023-08-21

Family

ID=56027205

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16724201.5T PL3291820T3 (pl) 2015-05-06 2016-05-05 Preparat hydrożelowy o łagodnej przyczepności

Country Status (14)

Country Link
US (2) US9987362B2 (pl)
EP (1) EP3291820B1 (pl)
CN (1) CN107530277A (pl)
AR (2) AR104541A1 (pl)
AU (1) AU2016256858B2 (pl)
BR (1) BR112017023841B1 (pl)
CA (2) CA3077942C (pl)
CL (1) CL2017002801A1 (pl)
ES (1) ES2949838T3 (pl)
MX (1) MX370083B (pl)
PL (1) PL3291820T3 (pl)
RU (1) RU2693041C2 (pl)
UY (1) UY36676A (pl)
WO (1) WO2016179379A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018213433A1 (en) * 2017-05-16 2018-11-22 Biocure, Inc. Hydrogel medical adhesives
US12240973B2 (en) * 2017-10-23 2025-03-04 Endologix Llc Endoluminal device and polymer

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113854A (en) 1977-01-10 1978-09-12 Minnesota Mining And Manufacturing Company Prophylactic treatment of mastitis
US4434181A (en) * 1981-12-07 1984-02-28 Fearing Manufacturing Co., Inc. Teat dip
US5017369A (en) * 1987-03-03 1991-05-21 Marhevka Virginia C Film-forming teat sealer for prevention of mastitis and use thereof
DE3934743A1 (de) 1989-10-18 1991-04-25 Eckold Vorrichtung Verfahren zum verbinden zweier bauteile
TW272976B (pl) 1993-08-06 1996-03-21 Ciba Geigy Ag
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
US6074663A (en) 1995-01-16 2000-06-13 Baxter International Inc. Method of using cross-linked fibrin material
AU4438696A (en) 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
US5849841A (en) 1995-02-03 1998-12-15 Ciba Vision Corporation Crosslinked polymers containing ester or amide groups
DK0807269T3 (da) 1995-02-03 2000-04-25 Novartis Ag Tværbindelige polymerer indeholdende fotoinitiatorer
TW349967B (en) 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
TW360671B (en) 1995-02-03 1999-06-11 Novartis Ag Process for producing mold body and the cross-linkable polymer used therein
JP3926847B2 (ja) 1995-12-08 2007-06-06 ノバルティス アクチエンゲゼルシャフト プラズマに誘導されたポリマー被覆
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US5819988A (en) 1997-04-01 1998-10-13 Sawhney; Ravi K. Double-barreled syringe with detachable locking mixing tip
US6395289B1 (en) * 1998-06-29 2002-05-28 Hydromer, Inc. Hydrophilic polymer blends used to prevent cow skin infections
DE69929071T2 (de) * 1998-09-21 2006-08-17 21St Century Medicine Inc., Cucamonga Verbesserte kälteschutzlösungen
ATE327262T1 (de) * 2000-03-13 2006-06-15 Biocure Inc Zusammensetzungen zur erhöhung des gewebevolumens und beschichtungszusammensetzungen
WO2001068720A1 (en) 2000-03-13 2001-09-20 Biocure, Inc. Embolic compositions
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
US20020122771A1 (en) 2000-09-23 2002-09-05 Troy Holland Spray hydrogel wound dressings
NZ531618A (en) 2001-09-10 2005-03-24 Bimeda Res & Dev Ltd A bio-security system
AU2002359410A1 (en) 2001-11-16 2003-06-10 Biocure, Inc. Methods for initiating in situ formation of hydrogels
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
US20060073216A1 (en) * 2002-12-26 2006-04-06 Solution Biosciences, Inc. Compositions and methods for control of bovine mastitis
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2004087007A2 (en) 2003-03-25 2004-10-14 Biocure, Inc. Hydrogel string medical device
EP1718237A1 (en) 2004-02-02 2006-11-08 Bimeda Research And Development Limited A method and device for treating a teat canal of an animal
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
US7235592B2 (en) * 2004-10-12 2007-06-26 Zimmer Gmbh PVA hydrogel
US20070249712A1 (en) * 2005-02-04 2007-10-25 Dee Alejandro O Peracetic teat dip
US8034824B2 (en) * 2005-10-12 2011-10-11 Kowa Co., Ltd. Iontophoretic preparation for treatment of breast cancer and/or mastitis
CA2634176A1 (en) 2005-10-26 2007-05-03 Biocure, Inc. Hydrogel spinal disc implants with swellable articles
WO2008153966A1 (en) 2007-06-11 2008-12-18 Biocure, Inc. Mucoadhesive vesicles for drug delivery
US20090149954A1 (en) 2007-12-07 2009-06-11 Xianbo Hu Bone substitute
US20090253650A1 (en) 2008-04-03 2009-10-08 Pongsamart S Teat antiseptic prepared from polysaccharide gel with bactericidal and immuno-stimulating activity isolated from durian fruit-rind
EP2332587A1 (de) * 2009-12-12 2011-06-15 Bayer MaterialScience AG Polyurethan-Dispersionen zur Versiegelung von Zitzen der Milchdrüse bei milchliefernden Tieren
US9232805B2 (en) * 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
US9040023B2 (en) 2011-05-27 2015-05-26 Zurex PharmaAgra Method of treating a mammalian teat and related compositions
GB201113606D0 (en) 2011-08-05 2011-09-21 Norbrook Lab Ltd Dual chamber syringe
RU2521401C1 (ru) * 2012-12-07 2014-06-27 ГНУ Краснодарский научно-исследовательский ветеринарный институт Российская академия сельскохозяйственных наук (Краснодарский НИВИ) Средство для профилактики мастита у дойных коров в сухостойный период
CN103275351A (zh) 2013-05-27 2013-09-04 山东赛克赛斯药业科技有限公司 一种交联剂、交联聚合物及其制备方法与应用
BR112016005795B1 (pt) 2013-09-16 2022-07-12 Zoetis Services Llc Conjunto de infusão

Also Published As

Publication number Publication date
US20160324969A1 (en) 2016-11-10
US9987362B2 (en) 2018-06-05
CA2984614C (en) 2020-07-14
CA2984614A1 (en) 2016-11-10
RU2017136861A3 (pl) 2019-06-06
AR132714A2 (es) 2025-07-23
BR112017023841A2 (pt) 2018-07-31
EP3291820B1 (en) 2023-05-24
AR104541A1 (es) 2017-07-26
CA3077942C (en) 2022-05-10
UY36676A (es) 2016-12-30
RU2017136861A (ru) 2019-06-06
AU2016256858B2 (en) 2020-10-08
RU2693041C2 (ru) 2019-07-01
MX2017014131A (es) 2018-03-15
MX370083B (es) 2019-11-29
CL2017002801A1 (es) 2018-05-11
US10449255B2 (en) 2019-10-22
WO2016179379A1 (en) 2016-11-10
NZ736305A (en) 2024-08-30
BR112017023841B1 (pt) 2023-04-18
CA3077942A1 (en) 2016-11-10
AU2016256858A1 (en) 2017-11-02
US20180264118A1 (en) 2018-09-20
ES2949838T3 (es) 2023-10-03
CN107530277A (zh) 2018-01-02
EP3291820A1 (en) 2018-03-14

Similar Documents

Publication Publication Date Title
EP3212216A4 (en) Interferon alpha2b variants
EP3150688A4 (en) Urea grease
PL3294206T3 (pl) Aplikator natryskowy o poszerzonym zakresie
PL3703655T3 (pl) Żel do wytwarzania aerozolu
EP3238692A4 (en) Hydrogel composition
GB201718035D0 (en) Aerosolisable formulation
PL3703656T3 (pl) Żel do wytwarzania aerozolu
GB201514758D0 (en) Formulation
ES2873376T5 (en) Maropitant formulation
ZA201802040B (en) Hydrogel composite depot formulation
GB201713724D0 (en) Formulation
EP3279100A4 (en) Can body
EP3162863A4 (en) Coating agent
GB201719464D0 (en) Formulation
GB201706969D0 (en) Formulation
EP3294797A4 (en) HYDROGEL FORMULATION WITH EASY LIABILITY
EP3258209A4 (en) Structured body
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
GB201715710D0 (en) Aerosolisable gel
GB201715717D0 (en) Aerosolisable gel
GB201720808D0 (en) Formulation
GB201718046D0 (en) Formulation
GB201702058D0 (en) Formulation